Stocks to sell

Blue-chip stocks are considered a more conservative way to invest, relative to more speculative names like early-stage growth stocks or penny stocks. However, that doesn’t mean owning them offers a guaranteed path to solid returns. At any given time, there are stocks in the blue-chip category that are not worth owning, at all. In some cases,

When a company issues a quarterly press release, typically it will put a positive spin on the company’s recent performance. That’s fine, but it means that investors should view Plug Power’s (NASDAQ:PLUG) latest earnings letter with a skeptical eye. After delving into the data, financial traders should seriously think about avoiding PLUG stock. The point

Whether you’re risk-inclined or not, Tilray Brands (NASDAQ:TLRY) isn’t a promising investment as a cannabis stock, let alone an alcohol play.  The company has made some moves within the alcohol sector,which I’ll get to in a minute, but its core business continues to underperform. The company’s recent earnings reinforce the view that this is likely

With Lucid Group (NASDAQ:LCID) shares slumping back to their 52-week low, plenty are curious whether LCID stock could soon make a comeback. This is due largely to LCID’s high short interest. In the eyes of risk-hungry traders, this factor points to an increased potential for a “short squeeze,” or a big run-up in shares caused

If any company is a darling on Wall Street in 2023, it’s definitely Nvidia (NASDAQ:NVDA). Analysts scrambled to lift their ratings and price targets on NVDA stock after its spectacular rally this year. Now, a call for clear-minded thinking is needed as a major near-term event could shut the party down. There’s no disputing that Nvidia

So far this month, Mullen Automotive (NASDAQ:MULN) has popped back on the radars of many investors. A big reason for this is several major developments directly related to MULN stock. These include announced progress with some of the early-stage electric vehicle maker’s growth efforts. A reverse-stock split, which will enable Mullen to keep its Nasdaq

Dividend stocks have become investors’ favorites in recent months. Tech turbulence and high-interest rates combined to make high-yield stocks an alternative to riskier equities while still beating the yield on fixed-income investments like treasuries. Unfortunately, many investors chase the bottom-line yield stat without looking too closely into the underlying company. Dividend stocks are usually seen

With stocks with high exposure to the artificial intelligence mega-trend pulling back recently, now may be the time to make an exit from overvalued AI stocks. Since late last year, when the launch of OpenAI’s generative AI chatbot ChatGPT kicked off a massive move by big tech into this new digital frontier, investors responded by

If you are a public equities investor betting on the digital economy, semiconductor stocks would have to be in your portfolio. Semiconductors are tiny electronic devices powering everything from our smartphones and personal computers to cars and commercial airplanes. If you take any run-of-the-mill semiconductor exchange-traded fund (ETF), say, the iShares Semiconductor ETF (NASDAQ:SOXX), many

Adam Aron, the CEO of global movie-theater chain AMC Entertainment (NYSE:AMC), cited the new Barbie movie in the company’s latest quarterly earnings report. I suppose we should have expected Aron to be enthused about Barbie‘s success. But will it be enough to bring AMC stock back to its former glory? Not likely. AMC Entertainment’s second-quarter results weren’t

There’s been plenty of talk about a recession that hasn’t arrived. Although the recession talks have been around for a few years, you can only kick that can down the road so far before it comes full circle. The macroeconomic atmosphere is, to put it bluntly, horrible. Student loan payments will resume in September during

It has been a rough past couple of years for Tilray Brands (NASDAQ:TLRY), but more recently, things have started to look up for TLRY stock. Last month, shares in the Canada-based cannabis company began to rally again, on the heels of a well-received quarterly earnings release. Last week, shares spiked in price yet again, except

Investors seeking defensive exposure in this market may turn their attention to mining socks. These companies, involved in locating, extracting, and processing valuable minerals vital for global industries, play an essential role as a growth engine for the global economy. Without various important base metals, entire industries wouldn’t be possible. Indeed, these companies may be

Chimerix (NASDAQ:CMRX), like most clinical-stage biotech stocks, is without question a high-risk play. Yet in contrast to other biotechs, where high potential rewards can outweigh this high risk, that is not necessarily the case here with CMRX stock. Sure, on paper, Chimerix’s future prospects appear very promising. Last year, the company sold a treatment that

By no means is this discussion about meme stocks to sell an indication that you should avoid the sector altogether. Sometimes, it’s good to just have fun (responsibly, of course) in the market. Ultimately, you never know if that wild contrarian wager might turn into something substantive. That, of course, is the main temptation of

As much as I love good dividend stocks, I have very little patience for F-rated dividend stocks that do nothing but drag your portfolio down. As an investor, you deserve better! A great dividend stock can make all the difference in your portfolio. By reinvesting dividends, growth investors can increase their positions and investing power

For a hot minute, Wall Street loved electric vehicle (EV) battery technology company QuantumScape (NYSE:QS). Then, financial traders turned against the company and QS stock quickly coughed up its gains. Frankly, it’s just too risky to invest in QuantumScape now. Don’t get the wrong idea. The investing community is fickle, and any stock is susceptible

With pharmaceutical companies, it’s all about the pipeline of new medications. Drugmakers, and their pharma stocks, are judged based on sales of current medications and potential sales of future prescriptions. Analysts and investors alike are always on the lookout for the next blockbuster drug. This helps to explain why the stocks of pharmaceutical companies with

It’s the height of summer vacation season, and the stock market is taking a breather after its major rally earlier in the year. For active traders, much of the excitement has moved to penny stocks, with many low-priced equities making huge moves in recent weeks. Investors should avoid the urge to go plunging too aggressively

The U.S. equity valuations continue their remarkable trend upward, well beyond anyone’s expectations in 2023. The major indices appreciated amid expectations of a soft landing for the economy as the Federal Reserve battles inflation. While inflation still sits above the Federal Reserve’s target, it is well below where it was 12 months ago. However, despite